Microchip Technology Incorporated (MCHP) financial statements: income statement, balance sheet and cash flow
Microchip Technology Incorporated's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Mar 31, 2026 · FY), Microchip Technology Incorporated reported revenue of $4.7B (+7.1% year on year) and net income of $230.0M (+46100.0% year on year).
Income statement
Microchip Technology Incorporated income statement, fiscal years
Line item
Mar 31, 2026 · FY
Mar 31, 2025 · FY
Mar 31, 2024 · FY
Mar 31, 2023 · FY
Net sales
$4.7B
$4.4B
$7.6B
$8.4B
Cost of sales
$2.0B
$1.9B
$2.6B
$2.7B
Gross profit
$2.7B
$2.5B
$5.0B
$5.7B
Research and development
$1.1B
$983.8M
$1.1B
$1.1B
Selling, general and administrative
$674.3M
$617.7M
$734.2M
$797.7M
Amortization of acquired intangible assets
$431.1M
$490.9M
$605.4M
$669.9M
Special charges (income) and other, net
$39.7M
$79.2M
($12.3M)
($4.0M)
Operating expenses
$2.2B
$2.2B
$2.4B
$2.6B
Operating income
$490.1M
$296.3M
$2.6B
$3.1B
Interest income
$11.4M
$9.2M
$7.6M
$2.1M
Interest expense
($221.3M)
($259.2M)
($198.3M)
($203.9M)
Loss on settlement of debt
$0
($1.7M)
($12.2M)
($8.3M)
Other loss, net
($6.7M)
($5.7M)
($2.2M)
$3.8M
Income before income taxes
$273.5M
$38.9M
$2.4B
$2.9B
Income tax provision
$43.5M
$39.4M
$459.0M
$672.0M
Net income (loss)
$230.0M
($500.0K)
$1.9B
$2.2B
Dividends on Series A Preferred Stock
($111.2M)
($2.2M)
—
—
Net income (loss) attributable to common stockholders
$118.8M
($2.7M)
—
—
Basic net income (loss) per common share (in dollars per share)
$0.22
-$0.01
$3.52
$4.07
Diluted net income (loss) per common share (in dollars per share)
$0.22
-$0.01
$3.48
$4.02
Dividends declared per common share (in dollars per share)
$1.82
$1.82
$1.68
$1.26
Basic common shares outstanding (in shares)
540.4M
537.3M
542.0M
550.4M
Diluted common shares outstanding (in shares)
545.2M
537.3M
548.0M
557.3M
Microchip Technology Incorporated income statement, quarters
Line item
Jun 30, 2026 · Q1
Dec 31, 2025 · Q3
Sep 30, 2025 · Q2
Jun 30, 2025 · Q1
Net sales
$1.5B
$1.2B
$1.1B
$1.1B
Cost of sales
$545.8M
$479.1M
$502.5M
$498.8M
Gross profit
$938.9M
$706.9M
$637.9M
$576.7M
Research and development
$308.9M
$274.3M
$262.3M
$255.5M
Selling, general and administrative
$184.3M
$168.5M
$172.3M
$159.3M
Amortization of acquired intangible assets
$90.0M
$107.6M
$108.1M
$107.6M
Special charges and other, net
$18.9M
$4.8M
$6.3M
$22.2M
Operating expenses
$602.1M
$555.2M
$549.0M
$544.6M
Operating income
$336.8M
$151.7M
$88.9M
$32.1M
Interest income
$1.4M
$1.3M
$3.6M
$4.9M
Interest expense
($48.8M)
($55.9M)
($56.3M)
($57.4M)
Other income, net
$500.0K
($3.5M)
($4.4M)
$4.6M
Income before income taxes
$289.9M
$93.6M
$31.8M
($15.8M)
Income tax provision
$60.1M
$30.9M
($9.9M)
$2.8M
Net income (loss)
$229.8M
$62.7M
$41.7M
($18.6M)
Dividends on Series A Preferred Stock
($27.8M)
($27.8M)
($27.8M)
($27.8M)
Net income (loss) attributable to common stockholders
$202.0M
$34.9M
$13.9M
($46.4M)
Basic net income (loss) per common share (in dollars per share)
$0.37
$0.06
$0.03
-$0.09
Diluted net income (loss) per common share (in dollars per share)
$0.37
$0.06
$0.03
-$0.09
Dividends declared per common share (in dollars per share)
$0.46
$0.46
$0.46
$0.46
Basic common shares outstanding (in shares)
542.5M
540.8M
540.0M
539.2M
Diluted common shares outstanding (in shares)
550.5M
545.5M
545.0M
539.2M
Balance sheet
Microchip Technology Incorporated balance sheet, fiscal years
Line item
Mar 31, 2026 · FY
Mar 31, 2025 · FY
Mar 31, 2024 · FY
Mar 31, 2023 · FY
Cash and cash equivalents
$240.3M
$771.7M
$319.7M
$234.0M
Accounts receivable, net
$894.7M
$689.7M
$1.1B
$1.3B
Inventories
$1.0B
$1.3B
$1.3B
$1.3B
Other current assets
$207.2M
$236.4M
$233.6M
$205.1M
Total current assets
$2.4B
$3.0B
$3.0B
$3.1B
Property, plant and equipment, net
$1.1B
$1.2B
$1.2B
$1.2B
Goodwill
$6.7B
$6.7B
$6.7B
$6.7B
Net Amount
$2.0B
$2.4B
$2.8B
$3.4B
Long-term deferred tax assets
$1.8B
$1.7B
$1.6B
$1.6B
Other assets
$364.4M
$397.7M
$611.9M
$457.2M
Total assets
$14.4B
$15.4B
$15.9B
$16.4B
Accounts payable
$205.6M
$160.6M
$213.0M
$396.9M
Accrued liabilities
$930.7M
$994.5M
$1.3B
$1.3B
Total current liabilities
$1.1B
$1.2B
$2.5B
$3.1B
Long-term debt
$5.5B
$5.6B
$5.0B
$5.0B
Long-term income tax payable
$570.9M
$633.4M
$649.2M
$705.7M
Long-term deferred tax liability
$25.1M
$33.8M
$28.8M
$42.7M
Other long-term liabilities
$709.0M
$843.6M
$1.0B
$948.0M
Preferred stock, $0.001 par value per share; authorized 5,000,000 shares; 7.50% Series A mandatory convertible preferred stock, 1,485,000 shares issued and outstanding at March 31, 2026 and March 31, 2025, with a liquidation preference of $1,000 per share, or $1,485.0 million in the aggregate
$0.00
$0.00
$0.00
$0.00
Common stock, $0.001 par value per share; authorized 900,000,000 shares; 578,423,967 shares issued and 542,079,011 shares outstanding at March 31, 2026; 577,996,915 shares issued and 538,704,604 shares outstanding at March 31, 2025
$600000.00
$600000.00
$500000.00
$500000.00
Additional paid-in capital
$4.1B
$3.9B
$2.5B
$2.4B
Common stock held in treasury: 36,344,956 shares at March 31, 2026; 39,292,311 shares at March 31, 2025
Preferred stock, $0.001 par value per share; authorized 5,000,000 shares; 7.50% Series A mandatory convertible preferred stock, 1,485,000 shares issued and outstanding at June 30, 2026 and March 31, 2026, with a liquidation preference of $1,000 per share, or $1,485.0 million in the aggregate
$0.00
$0.00
$0.00
$0.00
Common stock, $0.001 par value per share; authorized 900,000,000 shares; 578,424,252 shares issued and 543,008,365 shares outstanding at June 30, 2026; 578,423,967 shares issued and 542,079,011 shares outstanding at March 31, 2026
$600000.00
$600000.00
$600000.00
$600000.00
Additional paid-in capital
$4.1B
$4.1B
$4.0B
$4.0B
Common stock held in treasury: 35,415,887 shares at June 30, 2026; 36,344,956 shares at March 31, 2026
-2.5B
-2.6B
-2.6B
-2.6B
Accumulated other comprehensive loss
($3.7M)
($6.7M)
($6.2M)
($6.4M)
Retained earnings
$4.9B
$5.0B
$5.3B
$5.5B
Total stockholders' equity
$6.5B
$6.6B
$6.7B
$6.9B
Total liabilities and stockholders' equity
$14.4B
$14.3B
$14.5B
$15.0B
Cash flow statement
Microchip Technology Incorporated cash flow statement, fiscal years
Line item
Mar 31, 2026 · FY
Mar 31, 2025 · FY
Mar 31, 2024 · FY
Mar 31, 2023 · FY
Net income (loss)
$230.0M
($500.0K)
$1.9B
$2.2B
Depreciation and amortization
$689.3M
$750.1M
$879.5M
$998.4M
Deferred income taxes
($64.6M)
($143.3M)
($27.2M)
$205.5M
Share-based compensation expense related to equity incentive plans
$255.4M
$180.4M
$177.5M
$170.4M
Loss on settlement of debt
$0
$1.7M
$12.2M
$8.3M
Amortization of debt discount
$27.2M
$64.8M
$37.5M
$7.2M
Amortization of debt issuance costs
$5.9M
$7.8M
$7.3M
$9.5M
Impairment of intangible assets
$4.1M
$0
$1.8M
$1.8M
Other
($17.5M)
($63.0M)
($26.1M)
—
(Increase) decrease in accounts receivable
($204.5M)
$454.0M
$161.6M
($232.7M)
Decrease in inventories
$264.3M
$31.6M
$12.8M
($483.2M)
Increase (decrease) in accounts payable and accrued liabilities
$26.0M
($345.6M)
($148.4M)
$323.4M
Change in other assets and liabilities
($105.8M)
($38.1M)
($64.2M)
$404.5M
Change in income tax payable
($147.7M)
($1.8M)
($38.5M)
($28.0M)
Net cash provided by operating activities
$962.1M
$898.1M
$2.9B
$3.6B
Other investing
$1.3M
$2.4M
—
—
Proceeds from capital-related government incentives
$5.1M
$400.0K
$6.0M
—
Investments in other assets
($110.8M)
($164.6M)
($113.4M)
($114.2M)
Capital expenditures
($91.1M)
($126.0M)
($285.1M)
($486.2M)
Net cash used in investing activities
($195.5M)
($287.8M)
($392.1M)
($599.5M)
Proceeds from borrowings on Revolving Credit Facility
$0
$68.0M
$6.3B
$5.9B
Repayments of Revolving Credit Facility
$0
($68.0M)
($6.4B)
($7.2B)
Proceeds from borrowings on 2025 Term Loan Facility
$0
$0
$750.0M
—
Repayments of 2025 Term Loan Facility
$0
($750.0M)
—
—
Proceeds from issuance of Commercial Paper
$6.4B
$13.9B
$9.0B
—
Repayments of Commercial Paper
($6.2B)
($15.1B)
($7.7B)
—
Proceeds from issuance of senior notes
$0
$2.0B
$994.7M
$0
Repayment of senior notes
($1.2B)
($1.0B)
($3.4B)
$0
Proceeds from issuance of convertible debt
$900.0M
$1.3B
—
—
Payments on settlement of convertible debt
$0
($672.2M)
($132.8M)
($170.4M)
Issuance of Series A Preferred Stock
$0
$1.4B
—
—
Deferred financing costs
($16.6M)
($19.7M)
($3.0M)
$0
Purchase of capped call options
($68.0M)
($160.1M)
—
$0
Proceeds from sale of common stock
$61.7M
$65.4M
$82.1M
$82.3M
Tax payments related to shares withheld for vested RSUs
-51.4M
-57.6M
-61.1M
-75.8M
Repurchase of common stock
$0
($96.5M)
($982.1M)
($945.8M)
Payment of cash dividends on Series A Preferred Stock
($108.5M)
—
—
—
Payment of cash dividends on common stock
($984.0M)
—
—
—
Capital lease payments
($1.6M)
($1.6M)
($1.6M)
($800.0K)
Other Financing
($3.3M)
($5.6M)
—
—
Net cash used in financing activities
($1.3B)
($158.3M)
($2.4B)
($3.1B)
Net (decrease) increase in cash and cash equivalents
($531.4M)
$452.0M
$85.7M
($83.4M)
Cash and cash equivalents, at beginning of period
$771.7M
$319.7M
$234.0M
$317.4M
Cash and cash equivalents, at end of period
$240.3M
$771.7M
—
—
ROU assets obtained in exchange of lease liabilities